Anti-Infective Drugs Advisory Committee
Committee Meeting November 2, 2012 8:00 a.m. to 5:00 p.m.
Agenda: On November 2, 2012, the committee will discuss biologics licensing application (BLA) 125346, raxibacumab injection, a humanized monoclonal antibody against protective antigen of Bacillis anthracis, by Human Genome Sciences, Inc. for the proposed indication of treatment of inhalational anthrax.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment